Please assess the completion status of the following clinical trial:

Trial Title: SPP100 (Aliskiren) Regimen in Hypertensive Patients With Renal Dysfunction

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age: 20 - 80 years old~* Gender: Male or female~* Status: Outpatients~* Elevated Serum Creatinine~Exclusion Criteria:~* Patients suspected of malignant hypertension~* Patients with a clinically significant allergy~* Patients who have received other investigational drug Other protocol-defined inclusion/exclusion criteria may apply

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).